BriaCell Therapeutics Corp. (BCTX)
NASDAQ: BCTX · Real-Time Price · USD
0.705
-0.021 (-2.83%)
At close: Nov 6, 2024, 4:00 PM
0.710
+0.005 (0.71%)
After-hours: Nov 6, 2024, 6:57 PM EST

BriaCell Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Aug - Jul.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019 - 2015
Period Ending
Nov '24 Jul '24 Jul '23 Jul '22 Jul '21 Jul '20 2019 - 2015
Market Capitalization
2514106101795
Upgrade
Market Cap Growth
-87.19%-87.19%4.90%29.07%1427.02%-50.55%
Upgrade
Enterprise Value
24127757595
Upgrade
Last Close Price
0.700.756.696.505.087.20
Upgrade
PE Ratio
--2.58-5.15-3.75-1.66-1.28
Upgrade
PB Ratio
-5.08-5.08-28.189.822.84-1.43
Upgrade
P/FCF Ratio
-0.55-0.55-4.48-8.13-10.14-4.07
Upgrade
P/OCF Ratio
-0.57-0.57-4.48-8.13-10.14-4.07
Upgrade
EV/EBITDA Ratio
-0.37-0.37-3.33-3.73-8.45-1.35
Upgrade
EV/EBIT Ratio
-0.37-0.37-3.33-3.72-8.44-1.35
Upgrade
EV/FCF Ratio
-0.51-0.51-3.26-4.56-7.59-4.20
Upgrade
Debt / Equity Ratio
----0.00-0.11
Upgrade
Debt / FCF Ratio
----0.00-0.32
Upgrade
Quick Ratio
0.210.2111.8043.64102.880.01
Upgrade
Current Ratio
0.490.4914.9645.00103.810.07
Upgrade
Return on Equity (ROE)
---619.75%-141.25%-114.78%-
Upgrade
Return on Assets (ROA)
-126.11%-126.11%-41.71%-18.99%-14.89%-509.24%
Upgrade
Return on Capital (ROIC)
---444.01%-50.26%-35.58%-
Upgrade
Earnings Yield
-19.19%-35.14%-19.08%-26.45%-17.58%-78.18%
Upgrade
FCF Yield
-98.46%-180.30%-22.31%-12.30%-9.86%-24.59%
Upgrade
Buyback Yield / Dilution
-5.35%-5.35%-0.81%-242.82%-533.09%-23.16%
Upgrade
Total Shareholder Return
-5.35%-5.35%-0.81%-242.82%-533.09%-23.16%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.